...
首页> 外文期刊>World Journal of Surgical Oncology >Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters
【24h】

Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters

机译:巴基斯坦人群四抗体免疫组化技术检测大肠癌错配修复缺陷及其与组织病理学参数的关系

获取原文
           

摘要

Background Microsatellite instability (MSI) operates as the second major pathway in the colorectal carcinogenesis. Although genetic testing remains the gold standard for the detection of MSI, the College of American Pathologists (CAP) recommends an initial immunohistochemical workup with a four-antibody panel (MLH1, PMS2, MSH2, and MSH6) to screen for a defective mismatch repair system. An increased trend towards young age colorectal carcinoma (CRC) has been noticed in our population over recent years; however, neither screening for MSI by immunohistochemistry (IHC)/genetic testing was done nor were its morphological features studied. We aimed to determine the frequency of mismatch repair deficiency (dMMR) by loss of IHC expression of the aforementioned enzymes in CRC patients and its correlatation with clinicopathologic parameters. Methods This was a retrospective study conducted at Liaquat National Hospital, Karachi, between 2012 and 2015. A total of 100 cases of CRC were included in the study that underwent surgical resection. IHC stains using antibodies MLH1, PMS2, MSH2, and MSH6 were performed by DAKO EnVision method on representative tissue blocks. The results were interpreted by senior histopathologists and correlated with clinico-pathological parameters. Results A total of 100 cases of CRC were studied that included 51 males and 49 females. Thirty-four percent ( n =?34) of the patients showed loss of IHC staining for MMR markers. Combined loss of expression for MLH1/PMS2 were observed in 16% ( n =?16) of the cases. Loss of MSH2/MSH6 were seen in 6% ( n =?6) of the cases. Loss of expression for all markers were noted in 7% ( n =?7) of the cases. There were 5% ( n =?5) of the cases that showed isolated loss of MLH1 only. The tumors with dMMR status were significantly associated with right-sided location ( p =?0.013), exhibited intra-tumoral lymphocytosis ( p =?0.007), and lymphovascular invasion ( p =?0.043). No significant association was seen with gender, age, tumor stage, grade, or other morphological features. Conclusion The frequency of mismatch repair deficiency in CRC patients was found to be 34% in Pakistani population which warrants further genetic testing to exclude Lynch syndrome. Moreover, right-sided location and intra-tumoral lymphocyte count may be used to identify patients who may need further workup.
机译:背景技术微卫星不稳定性(MSI)是结肠直肠癌发生中的第二个主要途径。尽管基因检测仍然是检测MSI的金标准,但美国病理学家学院(CAP)建议使用四抗体面板(MLH1,PMS2,MSH2和MSH6)进行初始免疫组化检查,以筛选有缺陷的错配修复系统。近年来,在我们的人群中发现了年轻人结直肠癌(CRC)的增加趋势。然而,既没有通过免疫组织化学(IHC)/遗传学测试筛选MSI,也没有研究其形态特征。我们旨在确定CRC患者中上述酶的IHC表达缺失及其与临床病理参数的相关性,从而确定错配修复缺陷(dMMR)的频率。方法这是一项回顾性研究,于2012年至2015年在卡拉奇的利夸特国家医院进行。该研究共包括100例CRC的患者,均接受了手术切除。通过DAKO EnVision方法在代表性组织块上使用抗体MLH1,PMS2,MSH2和MSH6进行IHC染色。结果由高级组织病理学家解释,并与临床病理参数相关。结果共研究了100例CRC,其中男51例,女49例。 34%(n =?34)的患者显示MHC标记的IHC染色丢失。在16%(n =?16)的病例中观察到MLH1 / PMS2的联合表达丧失。在6%的病例中(n =?6)发现MSH2 / MSH6的丢失。在7%的病例中(n =?7),所有标志物的表达均下降。有5%(n =?5)的病例仅显示出MLH1的单独丢失。具有dMMR状态的肿瘤与右侧位置显着相关(p = 0.013),表现出肿瘤内淋巴细胞增多(p = 0.007)和淋巴管浸润(p = 0.043)。没有发现与性别,年龄,肿瘤分期,等级或其他形态特征有显着相关性。结论在巴基斯坦人群中,CRC患者错配修复缺陷的发生率为34%,这值得进一步进行基因检测以排除Lynch综合征。此外,右侧位置和肿瘤内淋巴细胞计数可用于识别可能需要进一步检查的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号